Ketotifen fumarate, 99%
Ketotifen fumarate, 99%
Ketotifen fumarate, 99%
Ketotifen fumarate, 99%
Thermo Scientific Chemicals

Ketotifen fumarate, 99%

CAS: 34580-14-8 | C23H23NO5S | 425.499 g/mol
Have Questions?
更改视图buttonViewtableView
数量:
250 mg
1 g
货号 J63708.MD
又称 J63708-MD
价格(CNY)
-
数量:
250 mg
请求批量或定制报价
化学标识符
CAS34580-14-8
IUPAC Name(2E)-but-2-enedioic acid; 2-(1-methylpiperidin-4-ylidene)-6-thiatricyclo[8.4.0.0³,⁷]tetradeca-1(14),3(7),4,10,12-pentaen-8-one
Molecular FormulaC23H23NO5S
InChI KeyYNQQEYBLVYAWNX-WLHGVMLRSA-N
SMILESOC(=O)C=CC(O)=O.CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=CC=CC=C12
查看更多内容
规格Specification Sheet规格表
Assay from Supplier's CofA≥98.5%
Appearance (Color)White to pale cream to pale yellow
FormPowder
Mass SpecConforms to structure
Ketotifen fumaratin is an H1 receptor antagonist. In its ophthalmic form, it is used to treat allergic conjunctivitis, or the itchy red eyes caused by allergies.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Solubility
Soluble in water (10 mg/ml), DMSO (100 mM), and methanol.

Notes
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Store away from strong oxidizing agents.
RUO – Research Use Only

General References:

  1. MD Gregg J. Berdycorrespondence,; MD Dennis L. Spangler,; MD George Bensch,; MD Susan S. Berdy,; OD Robert C. Brusatti. A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model. Clinical therapeutics. 2000, 22 (7), 826-833.
  2. Mayank Joshi,; Ambikanandan Misra.Dry powder inhalation of liposomal Ketotifen fumarate: formulation and characterization. International Journal of Pharmaceutics. 2001, 223 (1-2).